Primary Record
Deucravacitinib
- In stock
- 4,976 g
- Purity
- 99.7 %
- CAS
- 1609392-27-9
Compound Identifiers & Properties
- CAS
- 1609392-27-9
- PubChem CID
- 134821691
- SMILES
- [2H]C([2H])([2H])NC(=O)C1=NN=C(C=C1NC2=CC=CC(=C2OC)C3=NN(C=N3)C)NC(=O)C4CC4
- Canonical SMILES
- [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC
Names & Synonyms
- Deucravacitinib
- Sotyktu
- BMS-986165
- Tyk2-IN-4
- 1609392-27-9
- Sotyktu (TN)
- Deucravacitinib [USAN]
- N0A21N6RAU
- RefChem:58358
- BMS986165
- UNII-N0A21N6RAU
- Deucravacitinib (JAN/USAN)
- DEUCRAVACITINIB [INN]
- DEUCRAVACITINIB [JAN]
- MFCD31715455
- bms 986165
- orb1308545
- CHEMBL4435170
- DEUCRAVACITINIB [WHO-DD]
- SCHEMBL20520348
- SCHEMBL29424395
- Deucravacitinib(BMS986165)?
- GTPL10432
- C20H22N8O3
- DTXSID701358473
- GLXC-20380
- EX-A3154
- JPC39227
- BDBM50507816
- NSC825520
- s8879
- Tyk2-IN-4(BMS986165)
- WHO 11342
- AKOS040741395
- AT18623
- EBC-225024
- NSC-825520
- compound 11 [PMID: 31318208}
- NCGC00687789-01
- (BMS-986165)
- AC-31543
- MS-27491
- 6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide
- HY-117287
- CS-0065044
- J3.789.428A
- D11817
- A940215
- EN300-22276121
- 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide
- B1370-292590
- B2702-292590
- 6-[(Cyclopropylcarbonyl)amino]-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]-N-(methyl-d3)-3-pyridazinecarboxamide
- 6-cyclopropaneamido-4-{[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino}-N-(2H3)methylpyridazine-3-carboxamide
- 3-Pyridazinecarboxamide, 6-((cyclopropylcarbonyl)amino]-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)N-(methyl-d3)-
- 3-Pyridazinecarboxamide, 6-[(cyclopropylcarbonyl)amino]-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]-N-(methyl-d3)-
- 6-((cyclopropylcarbonyl)amino]-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-((2H3)methyl)pyridazine-3-carboxamide
- 6-cyclopropaneamido-4-{[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)phenyl]amino}-N-((2)H?)methylpyridazine-3-carboxamide
- 6-cyclopropaneamido-4-{[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)phenyl]amino}-N-(2H3)methylpyridazine-3-carboxamide
- Deucravacitinib; 3-Pyridazinecarboxamide, 6-[(cyclopropylcarbonyl)amino]-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]-N-(methyl-d3)-; 6-[(Cyclopropylcarbonyl)amino]-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]-N-(methyl-d3)-3-pyridazineca